Deliberations of an Advisory Committee regarding priorities, sources, and methods for collecting animal antimicrobial use data in the United States

DeVincent, Stephen J.; Viola, Christina

doi:10.1016/j.prevetmed.2005.09.021

Cited by 9 publications

(7 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Section: Discussionmentioning

confidence: 99%

“…The necessity for countries to develop surveillance systems specific to their regulatory and distribution systems and available data sources/collection methods has been identified (World Health Organization, 2001). As all data sources and collection methods have limitations, an optimal surveillance system will include more than one data source (DeVincent and Viola, 2006) Under current Canadian regulations, veterinary drugs can be used in an extra-label manner, including for species, routes of administration, and reasons other than those indicated on the label. The use of antimicrobials for growth-promotion is permitted.…”

Section: Antimicrobial Use Surveillance In Canadamentioning

confidence: 99%

See 1 more Smart Citation

Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) Farm Program: Results from Finisher Pig Surveillance

Deckert

Gow

Rosengren³

et al. 2010

Zoonoses and Public Health

View full text Add to dashboard Cite

Impacts• Farm level antimicrobial use (AMU) and antimicrobial resistance (AMR) surveillance data provide information on AMU by the end-user and AMR at the level where antimicrobials are used.• Antimicrobials considered very important to human health were not frequently used in Canadian sentinel grower-finisher swine herds and resistance to these antimicrobials was low.• A Canadian farm level surveillance program utilizing herd veterinarians and sentinel herds is feasible and effective.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Antimicrobial Use Surveillance In Canadamentioning

confidence: 99%

Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) Farm Program: Results from Finisher Pig Surveillance

Deckert

Gow

Rosengren³

et al. 2010

Zoonoses and Public Health

View full text Add to dashboard Cite

show abstract

“…Interestingly, the Swann recommendations of 1969 (135) were the first to call for a ban on nontherapeutic use in animals and agriculture, a reasonable but highly contentious suggestion that has been impossible to enforce in many countries to this day. Deception has played a role in this failure; many of the antimicrobials approved for treatment of humans are given to animals under the cover of different names for different uses, as described in the Report of the Advisory Committee on Animal Antimicrobial Use Data Collection in the United States of the Alliance for the Prudent Use of Antibiotics (47). Although the Netherlands and Scandinavia have successfully reduced resistance levels, it is clear that restriction of antibiotic use is difficult to implement on a global scale.…”

Section: How To Control or Reduce Antibiotic Resistance Developmentmentioning

confidence: 99%

Origins and Evolution of Antibiotic Resistance

Davies

2010

Microbiol Mol Biol Rev

4,756

3,296

View full text Add to dashboard Cite

SUMMARY Antibiotics have always been considered one of the wonder discoveries of the 20th century. This is true, but the real wonder is the rise of antibiotic resistance in hospitals, communities, and the environment concomitant with their use. The extraordinary genetic capacities of microbes have benefitted from man's overuse of antibiotics to exploit every source of resistance genes and every means of horizontal gene transmission to develop multiple mechanisms of resistance for each and every antibiotic introduced into practice clinically, agriculturally, or otherwise. This review presents the salient aspects of antibiotic resistance development over the past half-century, with the oft-restated conclusion that it is time to act. To achieve complete restitution of therapeutic applications of antibiotics, there is a need for more information on the role of environmental microbiomes in the rise of antibiotic resistance. In particular, creative approaches to the discovery of novel antibiotics and their expedited and controlled introduction to therapy are obligatory.

show abstract

“…However, there is a lack of comprehensive, systematically collected, or readily available veterinary prescribing data in the USA 137 and other countries 138 and a lack of consensus on the optimum approach to surveillance of antibiotic use in animals. 140 Other systematically targeted by hospital preadmission screening programmes, should be investigated in future risk assessment studies as a potential means of reducing the risk of incursion of epidemic strains.…”

Section: Risk Of Infections and Outbreaksmentioning

confidence: 99%

Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread

Clements

Magalhães

Tatem

et al. 2010

The Lancet Infectious Diseases

183

133

View full text Add to dashboard Cite

Highly virulent strains of Clostridium difficile have emerged since 2003, causing large outbreaks of severe, often fatal, colitis in North America and Europe. In 2008-10, virulent strains spread between continents, with the first reported cases of fluoroquinolone-resistant C difficile PCR ribotype 027 in three Asia-Pacific countries and Central America. We present a risk assessment framework for assessing risks of further worldwide spread of this pathogen. This framework first requires identification of potential vehicles of introduction, including international transfers of hospital patients, international tourism and migration, and trade in livestock, associated commodities, and foodstuffs. It then calls for assessment of the risks of pathogen release, of exposure of individuals if release happens, and of resulting outbreaks. Health departments in countries unaffected by outbreaks should assess the risk of introduction or reintroduction of C difficile PCR ribotype 027 using a structured risk-assessment approach.

show abstract

Deliberations of an Advisory Committee regarding priorities, sources, and methods for collecting animal antimicrobial use data in the United States

Cited by 9 publications

References 3 publications

Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) Farm Program: Results from Finisher Pig Surveillance

Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) Farm Program: Results from Finisher Pig Surveillance

Origins and Evolution of Antibiotic Resistance

Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread

Contact Info

Product

Resources

About